Advocating for a world where intellectual
property law serves the public interest.
We write to you as organisations and individuals representing researchers, educators, students, and the institutions that support them, to encourage WIPO to take a clear stand in favour of ensuring that intellectual property regimes are a support, and not a hindrance, to efforts to tackle both the Coronavirus outbreak and its consequences. The COVID-19 pandemic has shone a bright light
[Mike Palmedo and Margarita Gorospe] As schools have closed in response to the Coronavirus 19 pandemic, interest in online learning has increased dramatically. Online learning often involves distributing copyrighted works online, so its governed by copyright limitations that vary widely from one country to the next. Some countries allow teachers, parents, and/or students to share works or parts of works
[Yousuf A Vawda and Bonginkosi Shozi] Abstract: As we observe the 18th anniversary of the Doha Declaration on the TRIPS Agreement (Agreement on Trade-Related Aspects of Intellectual Property Rights) and Public Health, it is appropriate to take stock of intellectual property developments and endeavour to present a comprehensive account of the situation in the African continent in respect of the
[Interview by Victoria Heath and Brigitte Vézina]...When time is of the essence, like now with the COVID-19 pandemic, scientific research results must be made available as soon as possible so that other scientists, policymakers and the general population can rely on sound scientific data in their decision-making process. Contrary to the traditional publishing model, which puts scientific publications behind a
On 28th March 2019, South Africa’s Copyright Amendment Bill was approved by the upper house of Parliament in South Africa, the National Council of Provinces, clearing the way for the President to sign the Bill into law. The long awaited Bill brings the 1978 Copyright Act, adopted in a pre-internet era, into the digital age - rules regarding libraries, archives,
Big Pharma notched a regrettable victory in the early days of the COVID-19 response when it successfully blocked an enforceable reasonable-pricing clause from inclusion in the first $8.3 billion emergency spending bill. Although the bill contains a provision requiring “fair and reasonable pricing” for federal acquisitions and another authorizing the Secretary of Health and Human Services to take steps to
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources